FRESENIUS MEDICAL CARE AG: goodwill carrying amount
Goodwill carrying amount for FRESENIUS MEDICAL CARE AG. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All FRESENIUS MEDICAL CARE AG financial histories
What this measure means
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
Exact concept: us-gaap:Goodwill. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2008-12-31 to 2016-12-31. The SEC response was captured on 2026-09-19.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2016-12-31 | 13,666,446,000 | USD | 2017-02-22 | 20-F · 0001047469-17-000816 |
| At date | 2015-12-31 | 13,032,750,000 | USD | 2017-02-22 | 20-F · 0001047469-17-000816 |
| At date | 2014-12-31 | 13,082,180,000 | USD | 2017-02-22 | 20-F · 0001047469-17-000816 |
| At date | 2013-12-31 | 11,658,187,000 | USD | 2016-02-24 | 20-F · 0001047469-16-010364 |
| At date | 2012-12-31 | 11,421,889,000 | USD | 2014-02-25 | 20-F · 0001047469-14-001301 |
| At date | 2011-12-31 | 9,186,650,000 | USD | 2014-02-25 | 20-F · 0001047469-14-001301 |
| At date | 2010-12-31 | 159,949,000 | USD | 2013-02-26 | 20-F · 0001047469-13-001694 |
| At date | 2009-12-31 | 7,511,434,000 | USD | 2012-02-23 | 20-F · 0000950123-12-002984 |
| At date | 2008-12-31 | 7,309,910,000 | USD | 2011-03-25 | 20-F/A · 0001019056-11-000354 |
Related financial histories
- FRESENIUS MEDICAL CARE AG: total assets
- FRESENIUS MEDICAL CARE AG: total liabilities
- FRESENIUS MEDICAL CARE AG: stockholders equity
- FRESENIUS MEDICAL CARE AG: cash and cash equivalents
- FRESENIUS MEDICAL CARE AG: net income or loss
- FRESENIUS MEDICAL CARE AG: operating cash flow
- FRESENIUS MEDICAL CARE AG: capital expenditure payments
- FRESENIUS MEDICAL CARE AG: financing cash flow
- FRESENIUS MEDICAL CARE AG: investing cash flow
- FRESENIUS MEDICAL CARE AG: retained earnings or deficit
- FRESENIUS MEDICAL CARE AG: basic weighted-average shares
- FRESENIUS MEDICAL CARE AG: diluted weighted-average shares
- FRESENIUS MEDICAL CARE AG: basic earnings per share
- FRESENIUS MEDICAL CARE AG: diluted earnings per share
- FRESENIUS MEDICAL CARE AG: income tax expense or benefit
- FRESENIUS MEDICAL CARE AG: net property, plant and equipment
- FRESENIUS MEDICAL CARE AG: share-based compensation expense
- FRESENIUS MEDICAL CARE AG: operating income or loss
- FRESENIUS MEDICAL CARE AG: current assets
- FRESENIUS MEDICAL CARE AG: interest expense
- FRESENIUS MEDICAL CARE AG: current liabilities
- FRESENIUS MEDICAL CARE AG: current accounts payable
- FRESENIUS MEDICAL CARE AG: net current accounts receivable
- FRESENIUS MEDICAL CARE AG: net inventory
- FRESENIUS MEDICAL CARE AG: gross profit
- FRESENIUS MEDICAL CARE AG: cost of revenue
- FRESENIUS MEDICAL CARE AG: selling, general and administrative expense
- FRESENIUS MEDICAL CARE AG: research and development expense
Inspect the source
- Entity
- FRESENIUS MEDICAL CARE AG / CIK 0001333141
- Captured
- 2026-09-19T11:17:38.075Z
- SEC response SHA-256
e87bd4359ff04ac590c7c6db67d662bf0b7bf6cf5d3d8e5bcf17a7c91b1e4c28
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001333141.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))